Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FBIO Fortress Biotech Inc.

休市中 08-07 16:00:00 EDT

2.67

-0.10

-3.61%

盘后2.69

+0.02+0.75%

19:36 EDT

最高2.85	最低2.65	成交量58.00万
今开2.77	昨收2.77	日振幅7.22%
总市值8,869万	流通市值6,184万	总股本3,322万
成交额157.75万	换手率2.50%	流通股本2,316万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FBIO","market":"US","secType":"STK","nameCN":"Fortress Biotech Inc.","latestPrice":2.67,"timestamp":1786132800000,"preClose":2.77,"halted":0,"volume":579990,"hourTrading":{"tag":"盘后","latestPrice":2.69,"preClose":2.67,"latestTime":"19:36 EDT","volume":16869,"amount":45224.0199,"timestamp":1786145799135,"change":0.02,"changeRate":0.007491,"amplitude":0.017453},"delay":0,"changeRate":-0.03610108303249101,"floatShares":23162199,"shares":33219072,"eps":3.23,"marketStatus":"休市中","change":-0.1,"latestTime":"08-07 16:00:00 EDT","open":2.77,"high":2.85,"low":2.65,"amount":1577543.8005,"amplitude":0.072202,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1786348800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.77,"preHourTrading":{"tag":"盘前","latestPrice":2.78,"preClose":2.77,"latestTime":"09:25 EDT","volume":11938,"amount":33829.96409,"timestamp":1786109100076,"change":0.01,"changeRate":0.00361,"amplitude":0.033466},"postHourTrading":{"tag":"盘后","latestPrice":2.69,"preClose":2.67,"latestTime":"19:36 EDT","volume":16869,"amount":45224.0199,"timestamp":1786145799135,"change":0.02,"changeRate":0.007491,"amplitude":0.017453},"volumeRatio":0.546796,"impliedVol":1.4334,"impliedVolPercentile":0.5538},"requestUrl":"/m/hq/s/FBIO","defaultTab":"news","newsList":[{"id":"1122357969","title":"Fortress Biotech子公司Cyprium Therapeutics完成2.05亿美元罕见儿科疾病优先审评券出售","url":"https://stock-news.laohu8.com/highlight/detail?id=1122357969","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122357969?lang=zh_cn&edition=full","pubTime":"2026-03-31 04:07","pubTimestamp":1774901228,"startTime":"0","endTime":"0","summary":"Fortress Biotech旗下子公司Cyprium Therapeutics宣布，已成功完成一张罕见儿科疾病优先审评券的出售交易，成交金额达2.05亿美元。此次交易标志着公司在资产优化战略方面取得重要进展，为后续研发管线注入强劲资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158636643","title":"Fortress Biotech子公司Cyprium Therapeutics达成协议 以2.05亿美元出售罕见儿科疾病优先审评券","url":"https://stock-news.laohu8.com/highlight/detail?id=1158636643","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158636643?lang=zh_cn&edition=full","pubTime":"2026-02-23 22:25","pubTimestamp":1771856715,"startTime":"0","endTime":"0","summary":"Fortress Biotech旗下子公司Cyprium Therapeutics近日签署重要协议，将其持有的罕见儿科疾病优先审评凭证以2.05亿美元价格售出。这项交易标志着生物制药领域资产货币化的典型案例。\n优先审评券制度由美国FDA设立，旨在激励药企研发针对罕见儿科疾病的创新疗法。持有者可通过该凭证加速其他新药上市审评流程。此次交易不仅为Cyprium带来可观现金流，更凸显出稀有监管资产在医药市场的巨大价值。\n随着全球医药监管环境持续优化，此类优先审评券已成为稀缺资源。本次交易金额创下同类资产转让的新高，预计将对生物科技行业的资产估值体系产生深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155503909","title":"Fortress Biotech子公司Cyprium Therapeutics达成协议，以2.05亿美元出售罕见儿科疾病优先审评券","url":"https://stock-news.laohu8.com/highlight/detail?id=1155503909","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155503909?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:31","pubTimestamp":1771853480,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc.（简称Fortress Biotech）旗下子公司Cyprium Therapeutics已签署一项协议，将旗下持有的罕见儿科疾病优先审评券以2.05亿美元的价格出售。该交易有望为Cyprium Therapeutics带来可观的资金流入，进一步增强其在罕见病治疗领域的研发实力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167862155","title":"Avenue Therapeutics与Atx-04达成全球独家授权协议，用于庞贝氏病治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1167862155","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167862155?lang=zh_cn&edition=full","pubTime":"2026-02-23 21:02","pubTimestamp":1771851741,"startTime":"0","endTime":"0","summary":"Avenue Therapeutics, Inc. 已就Atx-04达成一项全球独家授权协议，该药物旨在治疗庞贝氏病。此次合作标志着公司在拓展其治疗产品线方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139","BK4007","ATXI"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fortressbiotech.com","stockEarnings":[{"period":"1week","weight":-0.147},{"period":"1month","weight":-0.11},{"period":"3month","weight":0.1172},{"period":"6month","weight":-0.1835},{"period":"1year","weight":0.4432},{"period":"ytd","weight":-0.2705}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1197},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.1339}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。该公司是一家生物制药公司，专注于收购和推进资产，通过产品收入、股权持有以及股息和特许权使用费收入流为股东提升长期价值。","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":0.066033},{"month":2,"riseRate":0.636364,"avgChangeRate":0.019184},{"month":3,"riseRate":0.363636,"avgChangeRate":-0.025325},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.021787},{"month":5,"riseRate":0.5,"avgChangeRate":-0.004832},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.009646},{"month":7,"riseRate":0.583333,"avgChangeRate":-0.005576},{"month":8,"riseRate":0.5,"avgChangeRate":0.041057},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.057104},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.163485},{"month":11,"riseRate":0.818182,"avgChangeRate":0.114632},{"month":12,"riseRate":0.545455,"avgChangeRate":0.07644}],"exchange":"NASDAQ","name":"Fortress Biotech Inc.","nameEN":"Fortress Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fortress Biotech Inc.,FBIO,Fortress Biotech Inc.股票,Fortress Biotech Inc.股票老虎,Fortress Biotech Inc.股票老虎国际,Fortress Biotech Inc.行情,Fortress Biotech Inc.股票行情,Fortress Biotech Inc.股价,Fortress Biotech Inc.股市,Fortress Biotech Inc.股票价格,Fortress Biotech Inc.股票交易,Fortress Biotech Inc.股票购买,Fortress Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}